

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.81034158 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.81034158 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.41121422 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.41121422 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.92350170 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.64827289 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30945357 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.18814588 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.18814588 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.18814588 |
| 11 | regulation of plasminogen activation (GO:0010755) | 6.10297544 |
| 12 | exogenous drug catabolic process (GO:0042738) | 6.09557404 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 6.06522606 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.88949631 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.81868071 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.81788661 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.80847878 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60139506 |
| 19 | intestinal cholesterol absorption (GO:0030299) | 5.58497587 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.46524668 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.44112341 |
| 22 | urea metabolic process (GO:0019627) | 5.22031112 |
| 23 | urea cycle (GO:0000050) | 5.22031112 |
| 24 | regulation of cholesterol esterification (GO:0010872) | 5.20125541 |
| 25 | protein carboxylation (GO:0018214) | 5.18421247 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18421247 |
| 27 | cysteine metabolic process (GO:0006534) | 5.17943668 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 5.12725260 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 5.10032050 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.07472223 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.00791936 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.99910132 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.98524702 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.96818877 |
| 35 | bile acid metabolic process (GO:0008206) | 4.95665841 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.85852623 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.85152218 |
| 38 | protein-lipid complex assembly (GO:0065005) | 4.84098145 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.81131232 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.81131232 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81131232 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.75453601 |
| 43 | cellular biogenic amine catabolic process (GO:0042402) | 4.70875723 |
| 44 | amine catabolic process (GO:0009310) | 4.70875723 |
| 45 | drug metabolic process (GO:0017144) | 4.68567989 |
| 46 | protein-lipid complex subunit organization (GO:0071825) | 4.63484267 |
| 47 | acute-phase response (GO:0006953) | 4.61709712 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61236069 |
| 49 | regulation of complement activation (GO:0030449) | 4.60204320 |
| 50 | phospholipid efflux (GO:0033700) | 4.59344568 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.58986116 |
| 52 | negative regulation of hemostasis (GO:1900047) | 4.58986116 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.58297688 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.58297688 |
| 55 | * alpha-amino acid catabolic process (GO:1901606) | 4.57474244 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.47698590 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.44759101 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.43774897 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.43696269 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.42527485 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.42527485 |
| 62 | aldehyde catabolic process (GO:0046185) | 4.41840739 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.41032603 |
| 64 | negative regulation of protein activation cascade (GO:2000258) | 4.40832225 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.40534680 |
| 66 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.37472614 |
| 67 | ethanol metabolic process (GO:0006067) | 4.34344459 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.33883781 |
| 69 | regulation of humoral immune response (GO:0002920) | 4.31582392 |
| 70 | glycine metabolic process (GO:0006544) | 4.31296420 |
| 71 | cholesterol efflux (GO:0033344) | 4.30754031 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.20713684 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.19174222 |
| 74 | serine family amino acid biosynthetic process (GO:0009070) | 4.18959720 |
| 75 | * cellular amino acid catabolic process (GO:0009063) | 4.18381804 |
| 76 | blood coagulation, intrinsic pathway (GO:0007597) | 4.17553225 |
| 77 | bile acid and bile salt transport (GO:0015721) | 4.14711174 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 4.12923835 |
| 79 | positive regulation of hemostasis (GO:1900048) | 4.12923835 |
| 80 | regulation of apoptotic cell clearance (GO:2000425) | 4.11241568 |
| 81 | lysine catabolic process (GO:0006554) | 4.09575250 |
| 82 | lysine metabolic process (GO:0006553) | 4.09575250 |
| 83 | negative regulation of wound healing (GO:0061045) | 4.07740626 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.05489302 |
| 85 | fibrinolysis (GO:0042730) | 4.04550879 |
| 86 | arginine metabolic process (GO:0006525) | 4.03143788 |
| 87 | oxidative demethylation (GO:0070989) | 4.02308326 |
| 88 | NAD biosynthetic process (GO:0009435) | 4.01921676 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01661400 |
| 90 | cellular glucuronidation (GO:0052695) | 4.00794586 |
| 91 | * glutamate metabolic process (GO:0006536) | 4.00558513 |
| 92 | heme transport (GO:0015886) | 3.97874340 |
| 93 | cofactor catabolic process (GO:0051187) | 3.95347596 |
| 94 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.94628870 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.93603879 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.92731561 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.92731561 |
| 98 | drug catabolic process (GO:0042737) | 3.89354351 |
| 99 | phenylpropanoid metabolic process (GO:0009698) | 3.89137145 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.85894393 |
| 101 | ketone body metabolic process (GO:1902224) | 3.85204666 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.84893494 |
| 103 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.80860469 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.80860469 |
| 105 | lipoprotein metabolic process (GO:0042157) | 3.80571897 |
| 106 | ethanol oxidation (GO:0006069) | 3.79644053 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79009859 |
| 108 | positive regulation of coagulation (GO:0050820) | 3.78150009 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77774010 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.76103613 |
| 111 | cytolysis (GO:0019835) | 3.75765357 |
| 112 | opsonization (GO:0008228) | 3.75727143 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.75398905 |
| 114 | * organic acid catabolic process (GO:0016054) | 3.70152840 |
| 115 | * carboxylic acid catabolic process (GO:0046395) | 3.70152840 |
| 116 | sterol homeostasis (GO:0055092) | 3.68553646 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.66658143 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.66658143 |
| 119 | short-chain fatty acid metabolic process (GO:0046459) | 3.65978744 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.65326724 |
| 121 | cholesterol transport (GO:0030301) | 3.65074837 |
| 122 | sterol transport (GO:0015918) | 3.65074837 |
| 123 | protein activation cascade (GO:0072376) | 3.63012533 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 3.60110149 |
| 125 | acetyl-CoA metabolic process (GO:0006084) | 3.59806774 |
| 126 | regulation of lipoprotein particle clearance (GO:0010984) | 3.57960597 |
| 127 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56621562 |
| 128 | negative regulation of complement activation (GO:0045916) | 3.55453059 |
| 129 | acute inflammatory response (GO:0002526) | 3.54280501 |
| 130 | response to nitrosative stress (GO:0051409) | 3.49047269 |
| 131 | very long-chain fatty acid metabolic process (GO:0000038) | 3.48167730 |
| 132 | complement activation, classical pathway (GO:0006958) | 3.47295558 |
| 133 | complement activation (GO:0006956) | 3.44620100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.86897613 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.15386914 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.58746386 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09266109 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.29192930 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21585641 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.20170354 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00281248 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.53590210 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09799080 |
| 11 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.06923077 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01407866 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4477659 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.96213450 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72123980 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.51222881 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37417294 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34060399 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33300284 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31929085 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30552248 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28966391 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24456456 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17311570 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16915602 |
| 26 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.14823032 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11589574 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10145384 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07350511 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05526220 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05071461 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98305843 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97517284 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95978403 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95340309 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94560053 |
| 37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94151257 |
| 38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93857464 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93544625 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93326383 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91998636 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91869095 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91426960 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86624184 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85870577 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84564196 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83992994 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83227582 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82362376 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81907615 |
| 51 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80530679 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79573096 |
| 53 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78771938 |
| 54 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77977778 |
| 55 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.76598932 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74173426 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72668126 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72475966 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.72046081 |
| 60 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72014720 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71530267 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71530267 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.71367560 |
| 64 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71307234 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71143240 |
| 66 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71100980 |
| 67 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.70602285 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 0.69544170 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69083645 |
| 70 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.68161662 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68050051 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.67671078 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66145756 |
| 74 | AR_20517297_ChIP-Seq_VCAP_Human | 0.65627983 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.65533833 |
| 76 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65018577 |
| 77 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64484648 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64112726 |
| 79 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.63765176 |
| 80 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.63683695 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.63394896 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63373960 |
| 83 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.63290389 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63231589 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63022263 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.62535202 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.62404889 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.62087292 |
| 89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61410659 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.61019142 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.60352904 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 0.59956040 |
| 93 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.59811976 |
| 94 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.59316306 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.59231945 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.59057318 |
| 97 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.58994625 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.58792642 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.58515458 |
| 100 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.57282496 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56987458 |
| 102 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.56911712 |
| 103 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56789903 |
| 104 | NCOR_22424771_ChIP-Seq_293T_Human | 0.56719790 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.56410989 |
| 106 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.56134690 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.55608365 |
| 108 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55159887 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.55089239 |
| 110 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.54654480 |
| 111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54275416 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54098959 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.54095883 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.53931368 |
| 115 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.53792446 |
| 116 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.53733434 |
| 117 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.53173285 |
| 118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52741860 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52659779 |
| 120 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.52605233 |
| 121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52574671 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.52470774 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.52282248 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.51864244 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51725519 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.51691762 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51331663 |
| 128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.51280535 |
| 129 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.51266360 |
| 130 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.51143734 |
| 131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50964424 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50566367 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50400445 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49952937 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49849549 |
| 136 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.49419788 |
| 137 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.49200511 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.48978069 |
| 139 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.48657598 |
| 140 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.47942593 |
| 141 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.47439498 |
| 142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46911917 |
| 143 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.46041822 |
| 144 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.45639834 |
| 145 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.43861006 |
| 146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.43861006 |
| 147 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43314854 |
| 148 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.43233037 |
| 149 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.42610828 |
| 150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.42591829 |
| 151 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.42561975 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42378096 |
| 153 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.41842122 |
| 154 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41820778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22618174 |
| 2 | MP0005360_urolithiasis | 7.31588443 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27841054 |
| 4 | MP0005365_abnormal_bile_salt | 5.88516556 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14504247 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.31944255 |
| 7 | MP0003252_abnormal_bile_duct | 3.59130945 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.42427167 |
| 9 | MP0003195_calcinosis | 3.37795210 |
| 10 | MP0009840_abnormal_foam_cell | 3.22491518 |
| 11 | MP0005332_abnormal_amino_acid | 2.97473990 |
| 12 | MP0005083_abnormal_biliary_tract | 2.82128824 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.49329012 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.34889924 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.08576935 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.04411313 |
| 17 | MP0000609_abnormal_liver_physiology | 1.97259912 |
| 18 | MP0005451_abnormal_body_composition | 1.87222099 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.86605391 |
| 20 | MP0003868_abnormal_feces_composition | 1.76371470 |
| 21 | MP0001764_abnormal_homeostasis | 1.75909400 |
| 22 | MP0009697_abnormal_copulation | 1.69730429 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.64831777 |
| 24 | MP0003011_delayed_dark_adaptation | 1.62866347 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51889363 |
| 26 | MP0003186_abnormal_redox_activity | 1.48775381 |
| 27 | MP0003122_maternal_imprinting | 1.47346602 |
| 28 | MP0005408_hypopigmentation | 1.25219239 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.24334270 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.23549852 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.19546769 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.17098405 |
| 33 | MP0001915_intracranial_hemorrhage | 1.14129482 |
| 34 | MP0005647_abnormal_sex_gland | 1.12995989 |
| 35 | MP0004381_abnormal_hair_follicle | 1.12251463 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.09374787 |
| 37 | MP0000604_amyloidosis | 1.09132438 |
| 38 | MP0009764_decreased_sensitivity_to | 1.08452735 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.06926500 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.06383604 |
| 41 | MP0003718_maternal_effect | 1.05462213 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 0.99104841 |
| 43 | MP0000598_abnormal_liver_morphology | 0.97909934 |
| 44 | MP0009763_increased_sensitivity_to | 0.95739079 |
| 45 | MP0003879_abnormal_hair_cell | 0.93825961 |
| 46 | MP0001661_extended_life_span | 0.93686588 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.92178010 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.89168155 |
| 49 | MP0003690_abnormal_glial_cell | 0.89097213 |
| 50 | MP0009379_abnormal_foot_pigmentation | 0.85673612 |
| 51 | MP0008469_abnormal_protein_level | 0.85338559 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.84862462 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.84380735 |
| 54 | MP0003329_amyloid_beta_deposits | 0.84362539 |
| 55 | MP0002254_reproductive_system_inflammat | 0.79360818 |
| 56 | MP0005535_abnormal_body_temperature | 0.75725229 |
| 57 | MP0005395_other_phenotype | 0.72433971 |
| 58 | MP0005670_abnormal_white_adipose | 0.72358636 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 0.71340338 |
| 60 | MP0002822_catalepsy | 0.67670087 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.67122688 |
| 62 | MP0000566_synostosis | 0.66949968 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.65482940 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.65336933 |
| 65 | MP0003123_paternal_imprinting | 0.63438062 |
| 66 | MP0005266_abnormal_metabolism | 0.62971050 |
| 67 | MP0000639_abnormal_adrenal_gland | 0.61595697 |
| 68 | MP0002971_abnormal_brown_adipose | 0.61368583 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.60517159 |
| 70 | MP0002282_abnormal_trachea_morphology | 0.59765058 |
| 71 | MP0001756_abnormal_urination | 0.59187267 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.58624853 |
| 73 | MP0003724_increased_susceptibility_to | 0.58586740 |
| 74 | MP0005334_abnormal_fat_pad | 0.56358623 |
| 75 | MP0008872_abnormal_physiological_respon | 0.56009138 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.52818785 |
| 77 | MP0004142_abnormal_muscle_tone | 0.49321183 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.48664957 |
| 79 | MP0002132_abnormal_respiratory_system | 0.48367218 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.47930370 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 0.45983232 |
| 82 | MP0000920_abnormal_myelination | 0.45815012 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.45107951 |
| 84 | MP0008873_increased_physiological_sensi | 0.44586281 |
| 85 | MP0005448_abnormal_energy_balance | 0.43547771 |
| 86 | MP0009115_abnormal_fat_cell | 0.42858461 |
| 87 | MP0008874_decreased_physiological_sensi | 0.41687304 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.41661116 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.40275848 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.40211710 |
| 91 | MP0003878_abnormal_ear_physiology | 0.40211710 |
| 92 | MP0004883_abnormal_blood_vessel | 0.40100001 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.39637589 |
| 94 | MP0004043_abnormal_pH_regulation | 0.39211909 |
| 95 | MP0004272_abnormal_basement_membrane | 0.39062228 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.38905216 |
| 97 | MP0002796_impaired_skin_barrier | 0.38826173 |
| 98 | MP0006082_CNS_inflammation | 0.36820065 |
| 99 | MP0000579_abnormal_nail_morphology | 0.36758974 |
| 100 | MP0003953_abnormal_hormone_level | 0.36720089 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.36485545 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.36104903 |
| 103 | MP0002837_dystrophic_cardiac_calcinosis | 0.35623448 |
| 104 | MP0005187_abnormal_penis_morphology | 0.35496888 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.34795325 |
| 106 | MP0003075_altered_response_to | 0.33953159 |
| 107 | MP0005409_darkened_coat_color | 0.33788351 |
| 108 | MP0005023_abnormal_wound_healing | 0.32812126 |
| 109 | MP0002970_abnormal_white_adipose | 0.32525991 |
| 110 | MP0005164_abnormal_response_to | 0.32091962 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.31913681 |
| 112 | MP0009053_abnormal_anal_canal | 0.31879647 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.31067515 |
| 114 | MP0001905_abnormal_dopamine_level | 0.30535347 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.30389362 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.29950968 |
| 117 | MP0002168_other_aberrant_phenotype | 0.28736092 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.28160230 |
| 119 | MP0001853_heart_inflammation | 0.27464692 |
| 120 | MP0004130_abnormal_muscle_cell | 0.27323521 |
| 121 | MP0004147_increased_porphyrin_level | 0.26902397 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.26690302 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.26207399 |
| 124 | MP0002928_abnormal_bile_duct | 0.25670617 |
| 125 | MP0000371_diluted_coat_color | 0.25373377 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.25037959 |
| 127 | MP0000249_abnormal_blood_vessel | 0.24817266 |
| 128 | MP0003115_abnormal_respiratory_system | 0.24629731 |
| 129 | MP0003632_abnormal_nervous_system | 0.24450248 |
| 130 | MP0001529_abnormal_vocalization | 0.24020453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30358342 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.93568146 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.66966371 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.66801220 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.26861981 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.02639238 |
| 7 | Xanthomatosis (HP:0000991) | 5.91102133 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.51753241 |
| 9 | Joint hemorrhage (HP:0005261) | 4.76932216 |
| 10 | Complement deficiency (HP:0004431) | 4.56948287 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.45740119 |
| 12 | Hyperglycinemia (HP:0002154) | 4.36842131 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 4.32322464 |
| 14 | Hyperammonemia (HP:0001987) | 4.28417864 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14689372 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13655572 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13410069 |
| 18 | Epidermoid cyst (HP:0200040) | 3.99589246 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96771115 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95006072 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.95006072 |
| 22 | Hyperglycinuria (HP:0003108) | 3.94115064 |
| 23 | Fat malabsorption (HP:0002630) | 3.93248161 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.88241384 |
| 25 | Ketosis (HP:0001946) | 3.88196484 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86670054 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84645629 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82084837 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.46001573 |
| 30 | Nephritis (HP:0000123) | 3.28871793 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.28272225 |
| 32 | Abnormality of complement system (HP:0005339) | 3.25896980 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23741094 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20672394 |
| 35 | Spontaneous abortion (HP:0005268) | 3.18239021 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.15996873 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.13379561 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.11474264 |
| 39 | Steatorrhea (HP:0002570) | 3.08775744 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.07238112 |
| 41 | Cerebral edema (HP:0002181) | 3.06109251 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.98283166 |
| 43 | Lethargy (HP:0001254) | 2.94704100 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.91969639 |
| 45 | Purpura (HP:0000979) | 2.91898843 |
| 46 | Metabolic acidosis (HP:0001942) | 2.72754658 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.64181378 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64181378 |
| 49 | Ketoacidosis (HP:0001993) | 2.62219710 |
| 50 | Vascular calcification (HP:0004934) | 2.60495243 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.54353437 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.45631644 |
| 53 | Amyloidosis (HP:0011034) | 2.44468793 |
| 54 | Myocardial infarction (HP:0001658) | 2.43836735 |
| 55 | Gout (HP:0001997) | 2.38574950 |
| 56 | Irritability (HP:0000737) | 2.37006500 |
| 57 | Pulmonary embolism (HP:0002204) | 2.34556243 |
| 58 | Skin nodule (HP:0200036) | 2.34072559 |
| 59 | Osteomalacia (HP:0002749) | 2.33841894 |
| 60 | Brushfield spots (HP:0001088) | 2.32773706 |
| 61 | Hypophosphatemic rickets (HP:0004912) | 2.31932662 |
| 62 | Acanthocytosis (HP:0001927) | 2.29972039 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.28559146 |
| 64 | Vomiting (HP:0002013) | 2.25761389 |
| 65 | Enlarged kidneys (HP:0000105) | 2.24672290 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.24043696 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.23828969 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.23357833 |
| 69 | Malnutrition (HP:0004395) | 2.21777385 |
| 70 | Glomerulonephritis (HP:0000099) | 2.21632865 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.20248954 |
| 72 | Glycosuria (HP:0003076) | 2.20248954 |
| 73 | Rickets (HP:0002748) | 2.18723146 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.17180071 |
| 75 | Cholecystitis (HP:0001082) | 2.17180071 |
| 76 | Proximal tubulopathy (HP:0000114) | 2.14301542 |
| 77 | Opisthotonus (HP:0002179) | 2.11897403 |
| 78 | Mitral stenosis (HP:0001718) | 2.11709167 |
| 79 | Pancreatitis (HP:0001733) | 2.11190180 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.11142373 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.10733857 |
| 82 | Acute encephalopathy (HP:0006846) | 2.10519449 |
| 83 | Cholelithiasis (HP:0001081) | 2.09515083 |
| 84 | Renal cortical cysts (HP:0000803) | 2.08827363 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.08101256 |
| 86 | Alkalosis (HP:0001948) | 2.08083477 |
| 87 | Confusion (HP:0001289) | 2.07615235 |
| 88 | Potter facies (HP:0002009) | 2.04654037 |
| 89 | Facial shape deformation (HP:0011334) | 2.04654037 |
| 90 | Increased serum pyruvate (HP:0003542) | 2.01771248 |
| 91 | Menorrhagia (HP:0000132) | 1.99555934 |
| 92 | Neonatal onset (HP:0003623) | 1.95099585 |
| 93 | Abnormality of carpal bone ossification (HP:0006257) | 1.94269425 |
| 94 | Gingival bleeding (HP:0000225) | 1.93278373 |
| 95 | Arthropathy (HP:0003040) | 1.92877667 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 1.92383525 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 1.91053748 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.91053748 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 1.89457489 |
| 100 | Hepatic necrosis (HP:0002605) | 1.89069794 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 1.87786029 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86231686 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85830764 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85605479 |
| 105 | Hyperventilation (HP:0002883) | 1.84847876 |
| 106 | Fair hair (HP:0002286) | 1.84122829 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.84079249 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81565723 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 1.81563088 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.81201790 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.81143329 |
| 112 | Elevated hepatic transaminases (HP:0002910) | 1.81074045 |
| 113 | Thrombophlebitis (HP:0004418) | 1.80937278 |
| 114 | Poikilocytosis (HP:0004447) | 1.80317156 |
| 115 | Bifid scrotum (HP:0000048) | 1.79297996 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79282521 |
| 117 | Abnormality of glycolysis (HP:0004366) | 1.78960323 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 1.78769399 |
| 119 | Spastic paraparesis (HP:0002313) | 1.78329824 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 1.77627755 |
| 121 | Epistaxis (HP:0000421) | 1.73478715 |
| 122 | Gangrene (HP:0100758) | 1.73110225 |
| 123 | Vaginal fistula (HP:0004320) | 1.67352663 |
| 124 | Widely patent fontanelles and sutures (HP:0004492) | 1.66420367 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.65039659 |
| 126 | Retinal atrophy (HP:0001105) | 1.63956349 |
| 127 | Increased serum ferritin (HP:0003281) | 1.63584918 |
| 128 | Reticulocytosis (HP:0001923) | 1.62784840 |
| 129 | Joint swelling (HP:0001386) | 1.61453627 |
| 130 | Abnormal platelet function (HP:0011869) | 1.61329896 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.61329896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.17095391 |
| 2 | FGFR3 | 3.90221511 |
| 3 | FGFR4 | 3.66135738 |
| 4 | IRAK3 | 3.41506312 |
| 5 | STK16 | 3.26273873 |
| 6 | ICK | 3.22404762 |
| 7 | INSRR | 2.93390282 |
| 8 | TRIB3 | 2.87787178 |
| 9 | SIK1 | 2.73123665 |
| 10 | RIPK1 | 2.63004705 |
| 11 | ERBB4 | 2.60396050 |
| 12 | DYRK1B | 2.48430993 |
| 13 | PBK | 2.36451690 |
| 14 | IRAK2 | 2.28379722 |
| 15 | TAOK3 | 2.22796632 |
| 16 | ABL2 | 1.99999842 |
| 17 | IRAK1 | 1.93239190 |
| 18 | CASK | 1.91602006 |
| 19 | PINK1 | 1.89941606 |
| 20 | CDK12 | 1.87492027 |
| 21 | MAP2K4 | 1.81417646 |
| 22 | PIK3CA | 1.76535692 |
| 23 | ERN1 | 1.76264348 |
| 24 | TYRO3 | 1.73774883 |
| 25 | OXSR1 | 1.70673307 |
| 26 | PDGFRA | 1.64117016 |
| 27 | EPHA4 | 1.63200541 |
| 28 | MAPK15 | 1.62365789 |
| 29 | MST1R | 1.61973764 |
| 30 | STK39 | 1.56276797 |
| 31 | KDR | 1.53912941 |
| 32 | EPHB1 | 1.48889147 |
| 33 | NTRK3 | 1.46238517 |
| 34 | PDK2 | 1.45267143 |
| 35 | PKN1 | 1.42790841 |
| 36 | PIK3CG | 1.41462924 |
| 37 | GRK1 | 1.41462383 |
| 38 | FGFR1 | 1.38854667 |
| 39 | PKN2 | 1.37314379 |
| 40 | MARK1 | 1.34010086 |
| 41 | IRAK4 | 1.31290852 |
| 42 | ZAK | 1.31236527 |
| 43 | CAMK2G | 1.27922247 |
| 44 | AKT3 | 1.23204842 |
| 45 | DAPK2 | 1.22297639 |
| 46 | MAPK11 | 1.18889922 |
| 47 | CSF1R | 1.17144317 |
| 48 | MAP2K3 | 1.17068763 |
| 49 | FGFR2 | 1.13168348 |
| 50 | MET | 1.12922624 |
| 51 | MAPK4 | 1.12368166 |
| 52 | RET | 1.11932259 |
| 53 | TIE1 | 1.10806812 |
| 54 | DDR2 | 1.09528603 |
| 55 | PDK1 | 1.08787846 |
| 56 | SIK2 | 1.08348656 |
| 57 | PLK4 | 1.04247280 |
| 58 | TYK2 | 1.01205887 |
| 59 | STK38L | 0.96915106 |
| 60 | PNCK | 0.95719391 |
| 61 | WNK1 | 0.94873311 |
| 62 | MAP3K14 | 0.93149728 |
| 63 | SGK2 | 0.92048277 |
| 64 | MAP3K11 | 0.91204147 |
| 65 | PRKAA1 | 0.91104212 |
| 66 | EEF2K | 0.89117162 |
| 67 | CSNK1G3 | 0.87284376 |
| 68 | SGK3 | 0.87088946 |
| 69 | PRKCZ | 0.86857651 |
| 70 | GRK6 | 0.85194090 |
| 71 | SGK1 | 0.84901560 |
| 72 | CDK6 | 0.84613879 |
| 73 | MAP3K2 | 0.82348815 |
| 74 | CAMK1G | 0.81875907 |
| 75 | MAPK7 | 0.81285338 |
| 76 | CSNK1G1 | 0.81098541 |
| 77 | CDK4 | 0.80684175 |
| 78 | ADRBK2 | 0.80662438 |
| 79 | CAMK2B | 0.80568193 |
| 80 | BMPR2 | 0.80129457 |
| 81 | WNK4 | 0.77821603 |
| 82 | BCR | 0.76575729 |
| 83 | PRKCQ | 0.76010155 |
| 84 | PRKCG | 0.74392303 |
| 85 | PRKAA2 | 0.74216260 |
| 86 | CDK7 | 0.70969692 |
| 87 | BLK | 0.66782894 |
| 88 | TGFBR2 | 0.66664779 |
| 89 | GRK7 | 0.66110897 |
| 90 | MAP3K1 | 0.65696649 |
| 91 | IGF1R | 0.65298862 |
| 92 | ERBB2 | 0.62987180 |
| 93 | PRKACG | 0.61803939 |
| 94 | CSNK1G2 | 0.60271565 |
| 95 | MAPK12 | 0.60048895 |
| 96 | CSNK1A1L | 0.56345264 |
| 97 | BUB1 | 0.55901919 |
| 98 | SMG1 | 0.55835003 |
| 99 | GSK3A | 0.55538324 |
| 100 | EPHA2 | 0.55268500 |
| 101 | MTOR | 0.54360700 |
| 102 | CAMK2D | 0.54213145 |
| 103 | SGK223 | 0.53797438 |
| 104 | SGK494 | 0.53797438 |
| 105 | CAMK2A | 0.53526581 |
| 106 | PTK6 | 0.53199161 |
| 107 | RPS6KB1 | 0.53190762 |
| 108 | WNK3 | 0.51501928 |
| 109 | CDC42BPA | 0.50175306 |
| 110 | BMPR1B | 0.49840038 |
| 111 | TLK1 | 0.49534214 |
| 112 | MATK | 0.49416300 |
| 113 | CAMK1D | 0.48451516 |
| 114 | PRKG1 | 0.48200161 |
| 115 | DYRK2 | 0.47707243 |
| 116 | EPHA3 | 0.47677018 |
| 117 | NEK9 | 0.46952005 |
| 118 | PTK2 | 0.46825344 |
| 119 | CSK | 0.45193516 |
| 120 | MAP3K7 | 0.44978124 |
| 121 | PRKACA | 0.44970126 |
| 122 | CSNK1D | 0.43924150 |
| 123 | JAK2 | 0.43208016 |
| 124 | MAP3K3 | 0.43186395 |
| 125 | TAOK2 | 0.43007167 |
| 126 | TNIK | 0.42309157 |
| 127 | BRAF | 0.42305871 |
| 128 | FGR | 0.42020478 |
| 129 | SRC | 0.40238743 |
| 130 | PRKCA | 0.39721355 |
| 131 | IKBKE | 0.39362130 |
| 132 | RPS6KA3 | 0.38711375 |
| 133 | CSNK2A2 | 0.36992124 |
| 134 | GRK5 | 0.36824516 |
| 135 | LATS1 | 0.36389079 |
| 136 | EIF2AK2 | 0.35165705 |
| 137 | MAP2K7 | 0.33464060 |
| 138 | TBK1 | 0.31896181 |
| 139 | NME2 | 0.30646740 |
| 140 | MAPK3 | 0.30479957 |
| 141 | NEK6 | 0.30393152 |
| 142 | LMTK2 | 0.30276813 |
| 143 | PDPK1 | 0.30015319 |
| 144 | PDGFRB | 0.28800206 |
| 145 | CDK9 | 0.28623315 |
| 146 | PRKCE | 0.28313524 |
| 147 | BMX | 0.27940332 |
| 148 | AKT2 | 0.27915928 |
| 149 | CSNK1E | 0.27736673 |
| 150 | MAPKAPK3 | 0.27169001 |
| 151 | MAP2K6 | 0.26713290 |
| 152 | NUAK1 | 0.26336202 |
| 153 | PRKCB | 0.25947037 |
| 154 | CSNK2A1 | 0.25776044 |
| 155 | PRKACB | 0.25555737 |
| 156 | EIF2AK1 | 0.24981034 |
| 157 | MAP2K2 | 0.24232520 |
| 158 | KSR2 | 0.22830382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31263386 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11497100 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04003868 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96052258 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.82078819 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81368616 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.74375965 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65961544 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59230572 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57688935 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37147845 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31131602 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27979671 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.21521792 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20508922 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16217513 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14192337 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.04209886 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01755521 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97639550 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95257835 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.85764901 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85304937 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.83279343 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.80146589 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77230830 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75447431 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73134459 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72914168 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71434529 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65633719 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.63913598 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62600703 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59476590 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.56318681 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48520070 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48108812 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38169542 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36202500 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33653639 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32858233 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31036450 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31025775 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.30915607 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21050643 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.14965033 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13739094 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10333806 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09950363 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08564627 |
| 51 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08335695 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04501848 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02966973 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01049323 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00902804 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95667180 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92127099 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88507702 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87398100 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74844505 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72832000 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65340878 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.64711061 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64546755 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.57952858 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57747954 |
| 67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54112228 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52461241 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51430898 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49723564 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49480941 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42709451 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32957893 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.32542811 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30767218 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29199749 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26577388 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.25788481 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17984666 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17449447 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15157213 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15116870 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14028684 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13962234 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.13675025 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13101123 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.12629839 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09051407 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.05171077 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04558686 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04295945 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02181679 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.01744978 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.2020780 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1944873 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | -0.1932262 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1927659 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1912288 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1761832 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1701178 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | -0.1681085 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1309018 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1198053 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.1082492 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1061473 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | -0.0877983 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0821175 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | -0.0680457 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0456108 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0409982 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0327335 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0207561 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0169612 |

